Lobbying Filing Details

Total Spending

$45,000

Activities

1

Lobbyists

4

Gov't Entities

2

Filing Information
Filing UUID:
904b5958-750b-480a-8d97-b8e5134618fe
Type:
Q3 - 3rd Quarter - Report
Period:
2024 - 3rd Quarter (July 1 - Sep 30)
Date Posted:
October 21, 2024 at 2:21 PM
Income:
$45,000
Expenses:
$0
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: James Derderian
Registrant
STANTON PARK GROUP

government affairs

Annapolis, Maryland
Client
BRAEBURN PHARMACEUTICALS, INC.

pharmaceutical company

New Jersey, United States of America
Lobbying Activities (1)
Activity 1
Health Issues

Reducing stigma and promoting treatment of opioid use disorder; raising awareness of the benefits of medication assisted therapy (MAT); ensuring patient access to MAT; FDA approval and exclusivity process; patient access to practitioner-administered therapies Reauthorization of the Support Act.

Lobbyists (4)
  • VALERIE HENRY
  • JAMES DERDERIAN
  • JOSEPH RACHINSKY JR
  • MR. BRYAN WILLIAM WELLS
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES

Source: LDA.gov, data retrieved November 9, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.